drugset / Trial / NCT05138835
BOTOX® Cosmetic and Skin Health.
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.
Timeline
- Start
- 2021-11-11
- Primary completion
- 2022-11-11
- Completion
- 2022-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 0.1 unknown | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 unknown | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 24 unknown | Intramuscular |
Indications
No indication recorded.